☰
Summa Equity, a Sweden-based thematic investment firm that invests in enterprises that address global challenges, has reportedly purchased a majority stake of functional proteomics firm, Sengenics, who possesses a proprietary technology nam....
Takeda Pharmaceutical Company, the largest biopharmaceutical firm in Asia, has reportedly signed a five year strategic partnership with Accenture, the Irish professional services company, and AWS (Amazon Web Services), the renowned IT servi....
Bluegem Capital Partners, the London-based mid-market private equity Fund, has reportedly announced that its portfolio company Pool Service has acquired Italy-based Panzeri Diffusion. The firm that will be created from the merger of two gro....
MedAlliance, a medical technology company, has reportedly announced the enrollment of the 1st two patients in the Prospective Registry, PRISTINE, with SELUTION SLR™ 018 DEB. The PRISTINE trial will be conducted among patients with BTK....
Britain scientists have started a study to test if the Bacillus Calmette-Guerin (BCG) vaccine can help protect people against Covid-19, as part of a large-scale global trial. The BCG varanine was developed centuries ago to fight against tu....
Tipalti, a pioneer in global payables automation solution announced that it has raised $150 million at a valuation of over $2 billion, bringing the total capital raised to about $280M million for a B2B fintech company. The Series E round, ....
Flower One Holdings, Inc., has reportedly signed a term debt loan agreement for a sum of USD 39 million with Subversive REIT. As per the deal, Flower One gave Subversive REIT an option of two years for pursuing a sale-leaseback transaction ....
CLEAR, the secure identity enterprise, and LabCorp, the world’s leading life sciences organization focused on improving health and guiding patient care decisions announced their collaboration to allow users of the Health Pass mobile a....
Eureka Therapeutics Inc., a biotechnology firm that focuses on immunotherapies for the treatment of cancer, has reportedly commenced an ARYA-1 clinical trial to evaluate ET140203 ARTEMIS® T cell therapy in adult patients with HCC (Hepat....
TaiGen Biotechnology Co., Ltd., a Taiwan-based company that focuses on the development and commercialization of treatments for infectious diseases, cancers and diabetic complications, has announced that its influenza antiviral drug TG-....
